Ever since the pharmaceutical company Pfizer identified a very important side effect from the drug Sildenafil, which was designed to treat hypertension in the early 1990s, researches have been on a quest to find a drug that could effectively relieve the symptoms of female sexual dysfunction (FSD).
Sildenafil, better known as Viagra, was patented in 1996 and approved to treat male erectile dysfunction in 1998. Viagra is now the most popular prescription drug in the world with sales that exceed $1 billion a year.
After years of research the German pharmaceutical company Boehringer Ingelheim identified an important side effect from using the anti-depressant drug Flibanserin, and they expect broad-based female acceptance of the drug especially from women with symptoms of FSD.
Flibanserin may be called Girosa or Ectris when it is approved by the FDA and marketed as a prescription female Viagra, but it doesn’t work like Viagra works in men.
Flibanserin doesn’t play a role in increasing the amount of blood to the female genital region like the PDE-5 inhibitors in Viagra do in the male penis.
Flibanserin is a non-hormonal drug made from dopamine D4 receptors and serotonin 5-HT receptors. Flibanserin works by increasing the amount of dopamine and decreasing the amount of serotonin in the brain.
Boehringer believes Flibanserin will relieve the symptoms of hypoactive sexual desire disorder and pre-menopausal sexual arousal disorder when it is approved for medical use.
No one, including Boehringer, is completely sure how Flibanserin relieves FSD symptoms, but over five thousand women in four clinical trials in three hundred and fifty clinics worldwide have experienced positive results from using the drug.
Based on those results Boehringer is hoping to get FDA approval for medical use in the United States, but it’s a slow process.
Does Flibanserin Cause Side Effects?
Just like any prescription medication Flibanserin has a few noticeable side effects. Sinusitis, dizziness, headaches, and fatigue have been reported in the clinical studies, and some cases of nausea and diarrhea have also been reported, but there doesn’t appear to be any serious issues related to Flibanserin use.
The clinical studies seem to indicate that women begin to experience an increase in their sexual appetite when 100mg of Flibanserin is used daily for at least forty eight weeks.
It appears that most women in the study begin to notice an increase in their sexual fantasies and desires after forty weeks. Those results seem to confirm the fact that Flibanserin is a long term therapy that will require patience to get expected results.